Newsroom
In conversation with UNITE4TB Project Coordinator, Martin Boeree
In a recent interview for the IMI AMR Accelerator Newsletter, UNITE4TB Project Coordinator, Martin Boeree from Radboud University Medical Centre, spoke about the key objectives of the project and how work has progressed in these first six months.
“It's been an exciting and busy start to the project and I’m very happy with what we have achieved in these first six months. We had a kick-off meeting in June, shortly followed by a public outreach campaign, and several strategic meetings. We also recently had our first publication accepted with several more in the pipeline.
“There’s a long way to go yet, but this is a very strong collaboration of 30 partners from 13 countries, all committed to seizing the opportunity to substantially improve the current development of TB medicines. I look forward to what lies ahead for us in 2022 and beyond.”
Read the full interview here.
In other news, take a look at this recent IMI feature, showcasing UNITE4TB.